Stifel's Head of Therapeutics Paul Matteis shares his take on the sector and discusses names he covers that have key catalyst events

from BiotechTV - News · host BiotechTV

He shares his thoughts on uniQure, Xenon, Alkermes, Compass Pathways, GH Research MindMed, and Dyne.

Episode metadata supplied by the publisher feed · Published Nov 11, 2025

Embed this episode

Attribution link and audio player

Ready to play

Stifel's Head of Therapeutics Paul Matteis shares his take on the sector and discusses names he covers that have key catalyst events

0:00 13:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 13 minutes long.

This episode was published on November 11, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!